Kestra Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Sell
2,418
-483
-17% -$493K 0.06% 111
2026
Q1
$2.67M Buy
2,901
+732
+34% +$742K 0.05% 106
2025
Q4
$2.33M Sell
2,169
-7
-0.3% -$6.69K 0.06% 125
2025
Q3
$1.66M Sell
2,176
-1,302
-37% -$969K 0.04% 140
2025
Q2
$2.71M Buy
3,478
+257
+8% +$200K 0.08% 88
2025
Q1
$2.66M Buy
3,221
+490
+18% +$408K 0.08% 79
2024
Q4
$2.11M Sell
2,731
-241
-8% -$200K 0.08% 81
2024
Q3
$2.63M Buy
+2,972
New +$2.67M 0.11% 70

Other funds holding LLY

Kestra Investment Management's LLY Position: Q2 2026 in Review

Kestra Investment Management reduced its Eli Lilly (LLY) stake by 17% in Q2 2026, selling an estimated $493K and leaving 2,418 shares worth $2.9M. The position accounts for 0.06% of the portfolio, ranked #111.

Kestra Investment Management first reported a position in LLY in Q3 2024 and has held it in 8 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kestra Investment Management held 2,418 shares of Eli Lilly worth $2.9M as of Q2 2026.
  • Kestra Investment Management sold 483 Eli Lilly shares in Q2 2026, an estimated $493K.
  • Eli Lilly made up 0.06% of Kestra Investment Management's portfolio in Q2 2026, its #111 holding.
  • Kestra Investment Management first reported a position in Eli Lilly in Q3 2024 and has held it in 8 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.